Patient Preferences in Type 2 Diabetes Management
Summary
Patient preferences in type 2 diabetes management encompass individuals’ values and priorities when selecting and adhering to treatment regimens. These preferences span clinical outcomes such as glycaemic control, cardiovascular risk reduction and weight management, as well as process attributes including mode and frequency of administration, side-effect profiles and out-of-pocket costs. Recognition of heterogeneous preferences has driven the use of quantitative methods—such as discrete choice experiments and time trade-off interviews—to capture trade-offs that patients are willing to make between efficacy, safety and convenience. Integrating patient preferences into shared decision-making supports individualised care, enhances adherence and informs health technology assessments. Globally, understanding these preferences enables policymakers and clinicians to tailor guidelines and reimbursement decisions to what matters most to patients, ultimately improving clinical outcomes and quality of life.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Patient Preferences in Type 2 Diabetes Management publication trend
The graph below shows the total number of articles in patient preferences in type 2 diabetes management across all publications each year (not limited to Nature Index journals).
Technical terms
Discrete choice experiment (DCE): A survey method presenting hypothetical treatment profiles to elicit relative importance of attributes.
Time trade-off (TTO): A technique where respondents indicate the amount of life years they would trade for improved health states, yielding utilities.
Utility: A numeric measure of preference strength or quality of life associated with a health state, ranging from 0 (death) to 1 (full health).
Best–worst scaling: A preference elicitation method in which participants identify the most and least valued attributes within choice sets.
Health state vignette: A detailed description of a hypothetical patient scenario or treatment process used to gauge preferences in valuation exercises.
References
- Patient preferences for newer oral therapies in type 2 diabetes. International Journal of Cardiology (2022).
- Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China. The European Journal of Health Economics (2022).
- Willingness to Pay (WTP) for Newer Treatment Options for Diabetes: A Study Among Patients at a Tertiary Care Centre. Cureus (2024).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.